Format
Sort by

Send to

Choose Destination

Search results

Items: 18

1.

Systematic Redaction for Neuroimage Data.

Matlock M, Schimke N, Kong L, Macke S, Hale J.

Int J Comput Models Algorithms Med. 2012 Apr;3(2). doi: 10.4018/jcmam.2012040104.

2.

Security risks associated with radio frequency identification in medical environments.

Hawrylak PJ, Schimke N, Hale J, Papa M.

J Med Syst. 2012 Dec;36(6):3491-505. doi: 10.1007/s10916-011-9792-0. Epub 2011 Nov 3.

PMID:
22048780
3.

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.

Köllensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK; EMSA-SG.

Mov Disord. 2010 Nov 15;25(15):2604-12. doi: 10.1002/mds.23192.

PMID:
20922810
4.

Callosal tissue loss in multiple system atrophy--a one-year follow-up study.

Minnerop M, Lüders E, Specht K, Ruhlmann J, Schimke N, Thompson PM, Chou YY, Toga AW, Abele M, Wüllner U, Klockgether T.

Mov Disord. 2010 Nov 15;25(15):2613-20. doi: 10.1002/mds.23318.

5.

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).

Dodel R, Spottke A, Gerhard A, Reuss A, Reinecker S, Schimke N, Trenkwalder C, Sixel-Döring F, Herting B, Kamm C, Gasser T, Sawires M, Geser F, Köllensperger M, Seppi K, Kloss M, Krause M, Daniels C, Deuschl G, Böttger S, Naumann M, Lipp A, Gruber D, Kupsch A, Du Y, Turkheimer F, Brooks DJ, Klockgether T, Poewe W, Wenning G, Schade-Brittinger C, Oertel WH, Eggert K.

Mov Disord. 2010 Jan 15;25(1):97-107. doi: 10.1002/mds.22732.

PMID:
20014118
6.

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I; Huntington Study Group.

Neurology. 2009 Aug 4;73(5):385-92. doi: 10.1212/WNL.0b013e3181b04aa2.

7.

Red flags for multiple system atrophy.

Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Østergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK; European MSA Study Group.

Mov Disord. 2008 Jun 15;23(8):1093-9. doi: 10.1002/mds.21992.

PMID:
18442131
8.

Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters.

Minnerop M, Specht K, Ruhlmann J, Schimke N, Abele M, Weyer A, Wüllner U, Klockgether T.

Neuroimage. 2007 Jul 15;36(4):1086-95. Epub 2007 Apr 25.

PMID:
17512219
9.

Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).

Tackenberg B, Metz A, Unger M, Schimke N, Passow S, Hoeffken H, Hoffmann GF, Müller U, Nolte D, Oertel WH, Eggert K, Möller JC.

Mov Disord. 2007 Apr 30;22(6):900-2. No abstract available.

PMID:
17377924
10.

Health-related quality of life in multiple system atrophy.

Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK; European MSA-Study Group.

Mov Disord. 2006 Jun;21(6):809-15.

PMID:
16502399
11.

Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).

Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba JP, Ulmer H, Pellecchia MT, Barone P, Kim HT, Hooker J, Quinn NP, Cardozo A, Tolosa E, Abele M, Klockgether T, Østergaard K, Dupont E, Schimke N, Eggert KM, Oertel W, Djaldetti R, Poewe W; European MSA Study Group.

Mov Disord. 2006 Feb;21(2):179-86.

PMID:
16161136
12.

The European Multiple System Atrophy-Study Group (EMSA-SG).

Geser F, Seppi K, Stampfer-Kountchev M, Köllensperger M, Diem A, Ndayisaba JP, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa MM, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias CJ, Fowler C, Wood N, Quinn N, Widner H, Nilsson CF, Lindvall O, Schimke N, Eggert KM, Oertel W, del Sorbo F, Carella F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe W, Wenning GK; EMSA-SG.

J Neural Transm (Vienna). 2005 Dec;112(12):1677-86. Epub 2005 Jul 29. Review.

PMID:
16049636
13.

Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome.

Mrowka M, Jöbges M, Berding G, Schimke N, Shing M, Odin P.

J Neural Transm (Vienna). 2005 May;112(5):693-701. Epub 2004 Oct 27.

PMID:
15517434
14.

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.

Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, Hager C, Ludolph AC, Becker G, Osterhage J, Jost WH, Schrank B, Stein C, Kostopulos P, Lubik S, Wekwerth K, Dengler R, Troeger M, Wuerz A, Hoge A, Schrader C, Schimke N, Krampfl K, Petri S, Zierz S, Eger K, Neudecker S, Traufeller K, Sievert M, Neundörfer B, Hecht M; German vitamin E/ALS Study Group.

J Neural Transm (Vienna). 2005 May;112(5):649-60. Epub 2004 Oct 27.

PMID:
15517433
15.

Three-dimensional computerized analysis of diadochokinetic movements of Parkinsonian patients.

Joebges M, Mrowka M, Schimke N, Shing M, Dengler R, Odin P.

Acta Neurol Scand. 2003 Dec;108(6):415-23.

PMID:
14616294
16.

Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation.

Joebges EM, Heidemann M, Schimke N, Hecker H, Ennen JC, Weissenborn K.

J Hepatol. 2003 Mar;38(3):273-80.

PMID:
12586292
17.

[Cerebellar symptoms in motor neuron diseases. Special form of amyotrophic lateral sclerosis plus syndrome].

Schimke N, Krampfl K, Petri S, Dengler R, Bufler J.

Nervenarzt. 2002 Aug;73(8):751-3. German.

PMID:
12242962
18.

Clinical differentiation between Proteus syndrome and hemihyperplasia: description of a distinct form of hemihyperplasia.

Biesecker LG, Peters KF, Darling TN, Choyke P, Hill S, Schimke N, Cunningham M, Meltzer P, Cohen MM Jr.

Am J Med Genet. 1998 Oct 2;79(4):311-8.

PMID:
9781913
Items per page

Supplemental Content

Loading ...
Write to the Help Desk